000 01481 a2200409 4500
005 20250514001556.0
264 0 _c20010628
008 200106s 0 0 eng d
022 _a0022-3166
024 7 _a10.1093/jn/131.6.1694
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPace, D G
245 0 0 _aShort-term orlistat treatment does not affect mineral balance and bone turnover in obese men.
_h[electronic resource]
260 _bThe Journal of nutrition
_cJun 2001
300 _a1694-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Obesity Agents
_xpharmacology
650 0 4 _aBone and Bones
_xmetabolism
650 0 4 _aDietary Fats
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aElectrolytes
_xblood
650 0 4 _aEnergy Intake
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFeces
_xchemistry
650 0 4 _aGastrointestinal Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLactones
_xadverse effects
650 0 4 _aMale
650 0 4 _aMinerals
_xanalysis
650 0 4 _aObesity
_xdrug therapy
650 0 4 _aOrlistat
700 1 _aBlotner, S
700 1 _aGuerciolini, R
773 0 _tThe Journal of nutrition
_gvol. 131
_gno. 6
_gp. 1694-9
856 4 0 _uhttps://doi.org/10.1093/jn/131.6.1694
_zAvailable from publisher's website
999 _c11316101
_d11316101